BLOOD GENE BIOMARKERS TO DIAGNOSE AND PREDICT ACUTE REJECTION IN LIVER TRANSPLANT RECIPIENTS

摘要

The present disclosure is directed to materials and methods for predicting and diagnosing acute rejection in liver transplant recipients. Methods of the disclosure are useful, in various embodiments, for adjusting or initiating therapies (e.g., immunosuppressive (IS) therapy) in patients who would benefit therefrom.